Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article May 28 2025
RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation
Research Article May 22 2025
Plasminogen activation and plasmin activity are not required to prevent venous thrombosis/thromboembolism
Review Article May 15 2025
An Updated Understanding of Follicular Lymphoma Transformation
Review Article May 15 2025
How I Evaluate and Treat Resistance and Relapse in CML
Research Article May 15 2025
A phase 2 Trial of CHOP with Anti-CCR4 Antibody Mogamulizumab for older Patients with Adult T-Cell Leukemia/Lymphoma
Research Article May 15 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX group
Research Article May 13 2025
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA
Research Article May 13 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment
Review Article May 12 2025
How I approach hematopoietic stem cell transplantation for CML in a TKI world
Research Article May 7 2025
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
Research Article May 7 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT
Research Article May 7 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes
Research Article April 29 2025
The mitochondrial protease ClpP is a metabolic vulnerability and an immunogenic trigger against multiple myeloma.
Research Article April 25 2025
A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma
Review Article April 16 2025
How I individualize treatment for chronic-phase CML
Research Article April 8 2025
Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TN
Review Article March 25 2025
Structure-based design of therapeutics to control hemostasis
Review Article March 25 2025
How I treat chronic myeloid leukemia in children and adolescents
Review Article March 16 2025
Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics
Review Article February 28 2025
Exploring the thrombus niche: Lessons learned and potential therapeutic opportunities
Review Article February 28 2025
The Future of Follicular Lymphoma Management: Strategies on the Horizon
Review Article February 28 2025
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?
Review Article January 27 2025
Platelet activation and signaling in thrombus formation
Review Article January 27 2025
Factor XIII: Driving (Cross-)Links in Hemostasis, Thrombosis, and Disease
Review Article January 27 2025
Frontline treatment of follicular lymphoma: What will it take to change current practice?
Page 3 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals